These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27068976)

  • 1. Dopamine D4 receptor ubiquitination.
    Skieterska K; Rondou P; Van Craenenbroeck K
    Biochem Soc Trans; 2016 Apr; 44(2):601-5. PubMed ID: 27068976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLHL12 Promotes Non-Lysine Ubiquitination of the Dopamine Receptors D4.2 and D4.4, but Not of the ADHD-Associated D4.7 Variant.
    Skieterska K; Rondou P; Lintermans B; Van Craenenbroeck K
    PLoS One; 2015; 10(12):e0145654. PubMed ID: 26717573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the interaction between the dopamine D4 receptor, KLHL12 and β-arrestins.
    Skieterska K; Shen A; Clarisse D; Rondou P; Borroto-Escuela DO; Lintermans B; Fuxe K; Xiang YK; Van Craenenbroeck K
    Cell Signal; 2016 Aug; 28(8):1001-14. PubMed ID: 27155323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTB Protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligase.
    Rondou P; Haegeman G; Vanhoenacker P; Van Craenenbroeck K
    J Biol Chem; 2008 Apr; 283(17):11083-96. PubMed ID: 18303015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLHL12-mediated ubiquitination of the dopamine D4 receptor does not target the receptor for degradation.
    Rondou P; Skieterska K; Packeu A; Lintermans B; Vanhoenacker P; Vauquelin G; Haegeman G; Van Craenenbroeck K
    Cell Signal; 2010 Jun; 22(6):900-13. PubMed ID: 20100572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heteromerization between α
    Casadó-Anguera V; Moreno E; Sánchez-Soto M; Cai NS; Bonaventura J; Homar-Ruano P; Rubinstein M; Cortés A; Canela EI; Ferré S; Casadó V
    Pharmacol Res; 2021 Aug; 170():105745. PubMed ID: 34182128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and pharmacological role of the dopamine D
    Ferré S; Belcher AM; Bonaventura J; Quiroz C; Sánchez-Soto M; Casadó-Anguera V; Cai NS; Moreno E; Boateng CA; Keck TM; Florán B; Earley CJ; Ciruela F; Casadó V; Rubinstein M; Volkow ND
    Front Endocrinol (Lausanne); 2022; 13():1014678. PubMed ID: 36267569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isopeptide and ester bond ubiquitination both regulate degradation of the human dopamine receptor 4.
    Peeler JC; Schedin-Weiss S; Soula M; Kazmi MA; Sakmar TP
    J Biol Chem; 2017 Dec; 292(52):21623-21630. PubMed ID: 29101232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylation of the carboxyl-terminal tail of dopamine D
    Zhang X; Kim KM
    Biochem Biophys Res Commun; 2016 Oct; 479(2):398-403. PubMed ID: 27659709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate.
    Keck TM; Suchland KL; Jimenez CC; Grandy DK
    Pharmacol Biochem Behav; 2013 Feb; 103(4):831-41. PubMed ID: 23262298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-related metabolic effects of D4 dopamine receptor expression and activation.
    Hodgson NW; Waly MI; Trivedi MS; Power-Charnitsky VA; Deth RC
    Transl Psychiatry; 2019 Nov; 9(1):295. PubMed ID: 31719518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine D(4) receptor, the ultimate disordered protein.
    Woods AS
    J Recept Signal Transduct Res; 2010 Oct; 30(5):331-6. PubMed ID: 20836733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ADHD-linked human dopamine D4 receptor variant D4.7 induces over-suppression of NMDA receptor function in prefrontal cortex.
    Qin L; Liu W; Ma K; Wei J; Zhong P; Cho K; Yan Z
    Neurobiol Dis; 2016 Nov; 95():194-203. PubMed ID: 27475724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of dopamine D4 receptors in the paraventricular nucleus of the hypothalamus of male rats induces hyperphagia: involvement of glutamate.
    Tejas-Juárez JG; Cruz-Martínez AM; López-Alonso VE; García-Iglesias B; Mancilla-Díaz JM; Florán-Garduño B; Escartín-Pérez RE
    Physiol Behav; 2014 Jun; 133():272-81. PubMed ID: 24805978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the Functional Role of Dopamine D
    Sánchez-Soto M; Yano H; Cai NS; Casadó-Anguera V; Moreno E; Casadó V; Ferré S
    Mol Neurobiol; 2019 Jul; 56(7):4778-4785. PubMed ID: 30387076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant Functional Differences Between Dopamine D
    Homar-Ruano P; Cai NS; Casadó-Anguera V; Casadó V; Ferré S; Moreno E; Canela EI
    Mol Neurobiol; 2023 Nov; 60(11):6566-6583. PubMed ID: 37464153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH3 binding domains in the dopamine D4 receptor.
    Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
    Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of brain neurons expressing the dopamine D4 receptor gene using BAC transgenic mice.
    Noaín D; Avale ME; Wedemeyer C; Calvo D; Peper M; Rubinstein M
    Eur J Neurosci; 2006 Nov; 24(9):2429-38. PubMed ID: 17100831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice.
    Powell SB; Paulus MP; Hartman DS; Godel T; Geyer MA
    Neuropharmacology; 2003 Mar; 44(4):473-81. PubMed ID: 12646284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.